FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082119 [Registered on: 11/03/2025] Trial Registered Prospectively
Last Modified On: 11/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Assessment of cardiovascular disease related distress and psychosocial determinants: A prospective observational study 
Scientific Title of Study   Assessment of cardiovascular disease related distress and psychosocial determinants: A prospective observational study 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
IEC/BU/157/Faculty/9/352/2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kushal Pujara 
Designation  Adult Interventional Cardiologist 
Affiliation  B and M Patel Cardiac Centre Shree Krishna Hospital and Pramukh Swami Medical College Karamsad 
Address  B and M Patel Cardiac Centre Shree Krishna Hospital and Pramukh Swami Medical College Karamsad Gokal Nagar, Karamsad, Anand, Gujarat 388325

Anand
GUJARAT
388325
India 
Phone  9825175197  
Fax    
Email  drkushalpujara@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kushal Pujara 
Designation  Adult Interventional Cardiologist 
Affiliation  B and M Patel Cardiac Centre Shree Krishna Hospital and Pramukh Swami Medical College Karamsad 
Address  B and M Patel Cardiac Centre Shree Krishna Hospital and Pramukh Swami Medical College Karamsad Gokal Nagar, Karamsad, Anand, Gujarat 388325

Anand
GUJARAT
388325
India 
Phone  9825175197  
Fax    
Email  drkushalpujara@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Arshi Panchal 
Designation  Assistant Professor 
Affiliation  Anand Pharmacy College opposite Town Hall Rahtlav Mathiya Chora Anand Gujarat 388001 
Address  Anand Pharmacy College opposite Town Hall Rahtlav Mathiya Chora Anand Gujarat 388001

Anand
GUJARAT
388001
India 
Phone  7284856263  
Fax    
Email  arshipanchal99@gmail.com  
 
Source of Monetary or Material Support  
PRAMUKHSWAMI MEDICAL COLLEGE AND SHREE KRISHNA HOSPITAL KARAMSAD ANAND GUJARAT 
 
Primary Sponsor  
Name  DR KUSHAL PUJARA 
Address  B and M Patel Cardiac Centre Shree Krishna Hospital and Pramukh Swami Medical College, Karamsad 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR KUSHAL PUJARA  Shree Krishna Hospital and Pramukh Swami Medical College, Karamsad  B and M Patel Cardiac Centre Shree Krishna Hospital and Pramukhswami Medical College, Anand-Sojitra Rd, Gokul Nagar, Karamsad, Anand, Gujarat
Anand
GUJARAT 
9825175197

drkushalpujara@yahoo.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE-2 HM PATEL CENTER FOR MEDICAL CARE AND EDCUATION KARAMSAD  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I220||Subsequent ST elevation (STEMI) myocardial infarction of anterior wall,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NO INTERVENTION  NO INTERVENTION 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Patients willing to provide informed consent
Patients above 18 years of age
Patients with primary diagnosis of Acute Coronary Syndrome (Unstable angina, NSTEMI, STEMI)
Both Male and female patients are eligible 
 
ExclusionCriteria 
Details  Patients unwilling to provide consent
Patients with a history of any major surgery less than a month ago or undergoing a surgery
Patients who are Pregnant or lactating
Psychiatric patients with hindered mental capacity 
 
Method of Generating Random Sequence    
Method of Concealment    
Blinding/Masking    
Primary Outcome  
Outcome  TimePoints 
To measure the levels of distress related to cardiovascular condition.
To study
the impact of socio-economic status and psychosocial determinants on cardiovascular disease related
distress. 
15 months  
 
Secondary Outcome  
Outcome  TimePoints 
To measure the impact of
polypharmacy on cardiovascular disease related distress. 
15 months  
To prepare and validate Cardiac Distress
Inventory (CDI) and Adherence in Chronic Disease Scale (ACDS) in vernacular language (Gujarati) 
15 months 
To assess the level of medication adherence  15 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   24/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Cardiovascular disease (CVD) is a major health concern globally and in India contributing significantly to 
morbidity and mortality. While medical treatments and surgical interventions have advanced the 
psychosocial aspects of CVD such as patient distress and its impact on outcomes are less understood and 
thus often neglected. This study aims to address this gap by systematically evaluating the distress 
experienced by CVD patients. Understanding these relationships is crucial for developing holistic care 
strategies that encompasses both physical and psychological impacts ultimately aiming to improve patient 
management, enhance the quality of life and reduce the burden of CVD related distress.


 
Close